What to Expect from OncoCyte's Earnings

OncoCyte (NASDAQ:OCX) is set to give its latest quarterly earnings report on Tuesday, 2024-11-12. Here's what investors need to know before the announcement.

Analysts estimate that OncoCyte will report an earnings per share (EPS) of $-0.44.

The market awaits OncoCyte's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.

It's important for new investors to understand that guidance can be a significant driver of stock prices.

Performance in Previous Earnings

Last quarter the company beat EPS by $0.20, which was followed by a 1.3% increase in the share price the next day.

Here's a look at OncoCyte's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

-0.56

-0.67

-1.14

-1.01

EPS Actual

-0.36

-1.13

-2.18

-0.50

Price Change %

1.0%

4.0%

-9.0%

3.0%

OncoCyte Share Price Analysis

Shares of OncoCyte were trading at $2.86 as of November 08. Over the last 52-week period, shares are down 12.87%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Analyst Views on OncoCyte

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding OncoCyte.

OncoCyte has received a total of 1 ratings from analysts, with the consensus rating as Buy. With an ...